Even cheaper medicines helping you save

May 11, 2026

Anyone with Medicare now pays less for their Pharmaceutical Benefits Scheme (PBS) prescription medicines, with the Australian Government lowering the maximum patient cost of PBS medicines.

The general patient co-payment, which is the amount you pay for your PBS medicine, is now $25 for all Medicare card holders, down from $31.60. For Commonwealth concession cardholders, the PBS patient co-payment remains $7.70 until 2030.

PBS medicine costs can vary from pharmacy to pharmacy. If you choose a more expensive brand of medicine with a brand premium, you will pay a premium on top of your PBS co-payment amount. 

If your prescription costs less than $25, or $7.70 for concession card holders, retail pricing can vary. It can pay to compare prices at different pharmacies. 

So, how much could this save you?

An adult filling two PBS prescriptions per month paying the maximum patient co-payment would save $158.40 a year, while filling three prescriptions per month would result in annual savings of $237.60.

Newcastle pharmacy owner Lauren Wilson said lowering the PBS patient co-payment to $25 makes medicines more affordable.

“If you were paying $31.60, you now save $6.60 per prescription. So you don't need to wait to fill your prescription,” Lauren said. 

“The concessional card rate has been frozen to help families and individuals plan their medication costs because the rate is going to stay the same until 2030.” 

More information

Speak to your doctor or pharmacist about the cost of your medicines, or for more information visit health.gov.au/cheapermedicines.

Resources

The Department of Health, Disability and Ageing have released a suite of resources to help explain the latest updates. Resources include fact sheets, posters, videos and social media posts.

Visit health.gov.au/cheaper-medicines/resources to view and download all available resources. 

Latest news

September 13, 2026
South Eastern Melbourne PHN has launched the Clinical and Referral Guidance Hub (the Hub), a new platform providing primary care professionals in south east Melbourne with centralised access to local referral information and clinical guidance.
September 10, 2026
Sublocade® (long acting injectable buprenorphine) will be discontinued in Australia after 31 December 2026. The decision is not related to safety, quality or efficacy concerns and people currently receiving Sublocade® should continue their treatment as prescribed.
September 2, 2026
Thursday 10 September is World Suicide Prevention Day, a global day to raise awareness of suicide prevention and encourage open, compassionate conversations about suicide.